首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1477302

糖组学市场，按产品类型、按应用、按最终用户、按地理位置

Glycomics Market, By Product Type, By Application, By End User, By Geography

出版日期: 2024年03月27日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

糖组学市场预计 2024 年价值为 19.9 亿美元，预计到 2031 年将达到 48.2 亿美元，2024 年至 2031 年年复合成长率(CAGR) 为 13.5%。

报告范围		报告详情
基准年：	2023年	2024 年市场规模：	19.9 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测 2024 年至 2031 年复合年增长率：	13.50%	2031 年价值预测：	48.2 亿美元

图 1.Glycomics 市占率 (%)（按地区），2024 年

糖组学是对整个醣类（称为糖组）的大规模研究。糖组学致力于了解生物过程中糖的合成和功能。糖是所有生物的重要组成部分，在蛋白质和脂质中发挥结构或功能作用。糖组学专注于表征聚醣的结构、功能和相互作用，聚醣是附着在蛋白质和脂质上的糖或糖链。了解聚醣非常重要，因为它们影响关键的生物机制，包括细胞间通讯、细胞发育、免疫反应和疾病发病机制。质谱和微阵列等分析技术的进步使得高通量糖组分析成为可能，并有望在生物医学领域中广泛应用。

市场动态：

全球糖组学市场受到以下因素的推动：对糖基化及其在疾病中的作用的研究不断增加，政府和私人组织越来越多地支持糖组学研究，以及聚醣在开发癌症和其他疾病的诊断、生物标记和治疗方法中的应用不断增加。然而，由于聚醣的结构复杂性和缺乏标准化分析方法，市场成长可能会受到醣组分析技术挑战的限制。主要机会包括研究机构和公司之间的合作，将基础糖组学研究转化为商业生物製药应用，并将市场扩展到涉及工业产品开发和品质控制的非生物医学领域。

研究的主要特点：

该报告对全球糖组学市场进行了深入分析，并提供了以 2023 年为基准年的预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数描述了全球糖组学市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球糖组学市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
利害关係人可以透过用于分析全球糖组学市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
东协
澳洲
韩国
亚太地区其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
北非
中非
南非

第 9 章：竞争格局

公司简介
- RayBiotech Life, Inc.
- Shimadzu Corporation
- Asparia Glycomics
- Agilent Technologies Inc.
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- Merck KgaA
- New England Biolabs
- Takara Bio Inc
- Waters Corporation
- Danaher
- Lectenz Bio
- GlycoMimetics, Inc.
- Ludger Ltd.
- GlycoTech Corporation
- Glycosyn LLC
- Glykos, Inc.

第 10 章：分析师观点

命运之轮
分析师观点
连贯的机会图

第 11 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6796

The glycomics market is estimated to be valued at USD 1.99 Bn in 2024 and is expected to reach USD 4.82 Bn by 2031, growing at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 1.99 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	13.50%	2031 Value Projection:	US$ 4.82 Bn

Figure 1.Glycomics Market Share (%), By Region, 2024

Glycomics is the large-scale study of the entire complement of sugars, known as the glycome. Glycomics seeks to understand the synthesis and function of sugars in biological processes. Sugars are essential building blocks of all living things and serve structural or functional roles in proteins and lipids. Glycomics focuses on characterizing the structure, function, and interactions of glycans, which are sugars or sugar chains that attach to proteins and lipids. Understanding glycans is important as they influence key biological mechanisms including cell-cell communication, cell development, immune response, and disease pathogenesis. Advancements in analytical technologies, such as mass spectrometry and microarrays, have enabled high-throughput glycomic profiling and hold promise for widespread applications in biomedicine.

Market Dynamics:

The global glycomics market is driven by factors such as increasing research on glycosylation and its roles in diseases, growing initiatives by government and private organizations to support glycomics research, and rising applications of glycans in developing diagnostics, biomarkers, and therapeutics for cancer and other conditions. However, the market growth can be restrained by technical challenges in glycomic analysis due to the structural complexity of glycans and lack of standardized profiling methods. Major opportunities include partnerships between research institutes and companies to translate fundamental glycomics research into commercial biopharmaceutical applications as well as expanding the market into non-biomedical sectors involving industrial product development and quality control.

Key Features of the Study:

This report provides an in-depth analysis of the global glycomics market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global glycomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes RayBiotech Life, Inc., Shimadzu Corporation, Asparia Glycomics, Agilent Technologies Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Merck KgaA, New England Biolabs, Takara Bio Inc, Waters Corporation, Danaher, Lectenz Bio, GlycoMimetics, Inc., Ludger Ltd., GlycoTech Corporation, Glycosyn LLC, and Glykos, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global glycomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycomics market

Market Segmentation

By Product Type:
- Reagents
- Enzymes
- Kits
- Equipment
By Application:
- Diagnostics
- Drug Discovery & Development
- Others
By End User:
- Biopharmaceutical Companies
- Academic & Research Institutes
- CROs
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- RayBiotech Life, Inc.
- Shimadzu Corporation
- Asparia Glycomics
- Agilent Technologies Inc.
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- Merck KgaA
- New England Biolabs
- Takara Bio Inc
- Waters Corporation
- Danaher
- Lectenz Bio
- GlycoMimetics, Inc.
- Ludger Ltd.
- GlycoTech Corporation
- Glycosyn LLC
- Glykos, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Glycomics Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Glycomics Market, By Product Type, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Reagents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Enzymes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Kits
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Equipment
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

6. Global Glycomics Market, By Application, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Drug Discovery & Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

7. Global Glycomics Market, By End User, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biopharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
CROs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

8. Global Glycomics Market, By Region, 2019 - 2031, (USD BN)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- RayBiotech Life, Inc.*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Shimadzu Corporation
- Asparia Glycomics
- Agilent Technologies Inc.
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- Merck KgaA
- New England Biolabs
- Takara Bio Inc
- Waters Corporation
- Danaher
- Lectenz Bio
- GlycoMimetics, Inc.
- Ludger Ltd.
- GlycoTech Corporation
- Glycosyn LLC
- Glykos, Inc.